Showing results (11-20 of 43) with videos related to

Sort By:
Pageof 5
Experimental Biology and Medicine (Maywood, N.J.)|September 27, 2018
Drug discovery and development: Biomarkers of neurotoxicity and neurodegenerationAbigail L Walker, Syed Z Imam, Ruth A Roberts
Experimental Biology and Medicine (Maywood, N.J.)|December 8, 2023
Data science in drug discovery safety: Challenges and opportunitiesNicholas J Coltman, Ruth A Roberts, James E Sidaway
Drug Discovery Today|January 22, 2025
Is ChatGPT Ready for Public Use in Organ-Specific Drug Toxicity Research?Skylar Connor, Leihong Wu, Ruth A Roberts, et al.
Genomics|July 22, 2014
De novo LINE-1 retrotransposition in HepG2 cells preferentially targets gene poor regions of chromosome 13Pasano Bojang, Mark J Anderton, Ruth A Roberts, et al.
Drug Discovery Today|March 3, 2024
Generation of a drug-induced renal injury list to facilitate the development of new approach methodologies for nephrotoxicitySkylar Connor, Ting Li, Yanyan Qu, et al.
Molecular Oncology|May 8, 2013
Reprogramming of the HepG2 genome by long interspersed nuclear element-1Pasano Bojang, Ruth A Roberts, Mark J Anderton, et al.
Chemical Research in Toxicology|April 19, 2005
Characterization of an acute molecular marker of nongenotoxic rodent hepatocarcinogenesis by gene expression profiling in a long term clofibric acid studyCécile Michel, Ruth A Roberts, Chantal Desdouets, et al.
Drug Discovery Today|February 15, 2024
Academic drug discovery: Challenges and opportunitiesAngela J Murray, Liam R Cox, Holly V Adcock, et al.
Toxicology and Applied Pharmacology|April 20, 2004
Epigenetics and cancer: implications for drug discovery and safety assessmentJonathan G Moggs, Jay I Goodman, James E Trosko, et al.
The Journal of Biological Chemistry|December 19, 2002
Characterization of the transforming growth factor-beta 1-induced apoptotic transcriptome in FaO hepatoma cellsBeth Coyle, Caroline Freathy, Timothy W Gant, et al.
Pageof 5